Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
19.49
+1.08 (5.87%)
At close: Jul 27, 2026, 4:00 PM EDT
19.60
+0.11 (0.56%)
After-hours: Jul 27, 2026, 7:34 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $2.17 billion as of July 27, 2026. Its market cap has increased by 198.28% in one year.
Market Cap
2.17B
Enterprise Value
1.89B
1-Year Change
198.28%
Ranking
Category
Stock Price
$19.49
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $2.17B, an increase of 102.68%. That is a compound annual growth rate of 16.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 2.17B | 63.35% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 2.83B |
| Supernus Pharmaceuticals | 2.68B |
| BioCryst Pharmaceuticals | 2.37B |
| Prestige Consumer Healthcare | 2.35B |
| HUTCHMED (China) | 1.90B |
| Bausch Health Companies | 1.65B |
| ANI Pharmaceuticals | 1.65B |
| Trulieve Cannabis | 1.61B |